Po-Yu Chou

Po-Yu Chou completed his PhD in Pharmacy with a specialization in Pharmaceutical Sciences from Taipei Medical University, Taipei, Taiwan. He is a licensed pharmacist in Taiwan. His doctoral research focused on developing glycosylated PLGA nanoparticles as dendritic cell-targeting delivery vehicles for prophylactic and therapeutic cancer vaccination. Additionally, he investigated the development of glycosylated lipid nanoparticles loaded with the SARS-CoV-2 spike (S) protein to elicit efficient immunogenicity in mice by targeting dendritic cells. After earning his PhD, he worked as a postdoctoral researcher at the same institution, where he contributed to several projects, including the synthesis and evaluation of pharmacologically active compounds, such as LSD1/HDAC inhibitors, HSP90/LSD1 dual inhibitors, and related HDAC inhibitor derivatives. He is now a postdoctoral fellow in the Dr. Shyh-Dar Li’s Lab at the Laboratory of Targeted Drug Delivery and Nanomedicine, University of British Columbia (UBC). His current research focuses on designing polypeptide-based lipid nanoparticle delivery systems for mRNA and developing needle-free delivery technologies for proteins and peptides.